These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4019748)

  • 21. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays.
    Pachner AR; Sourojon M; Fuchs S
    J Neuroimmunol; 1986 Sep; 12(3):205-14. PubMed ID: 3488332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-like activity of a monoclonal anti-idiotypic antibody against an anti-acetylcholine receptor antibody.
    Lefvert AK; Fulpius BW
    Scand J Immunol; 1984 May; 19(5):485-9. PubMed ID: 6729408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiotypic network connectivity and a possible cause of myasthenia gravis.
    Dwyer DS; Vakil M; Kearney JF
    J Exp Med; 1986 Oct; 164(4):1310-8. PubMed ID: 2428915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of monoclonal antiacetylcholine receptor antibodies to investigate the macrophage inflammation of acute experimental myasthenia gravis: refractoriness to a second episode of acute disease.
    Corey AL; Richman DP; Shuman CA; Gomez CM; Arnason BG
    Neurology; 1985 Oct; 35(10):1455-60. PubMed ID: 3875805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of an idiotype associated with antibodies responsible for neuromuscular dysfunction in rats with experimental autoimmune myasthenia gravis.
    Thompson PA; Edlund SA; Krolick KA
    Clin Immunol Immunopathol; 1995 Apr; 75(1):57-67. PubMed ID: 7882593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody heterogeneity and specificity in myasthenia gravis.
    Vincent A; Whiting PJ; Schluep M; Heidenreich F; Lang B; Roberts A; Willcox N; Newsom-Davis J
    Ann N Y Acad Sci; 1987; 505():106-20. PubMed ID: 2446546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of antibody responses to the acetylcholine receptor by natural antibodies.
    Sundblad A; Hauser S; Holmberg D; Cazenave PA; Coutinho A
    Eur J Immunol; 1989 Aug; 19(8):1425-30. PubMed ID: 2776827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auto-anti-idiotype: a basis for autoimmunity and a strategy for anti-receptor antibodies.
    Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Sarangarajan R; Rajagopalan R; Cayanis E; Edelman IS; Penn AS
    Immunol Rev; 1986 Dec; 94():23-37. PubMed ID: 3492425
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of experimental myasthenia with autologous idiotypes linked to muramyl dipeptide.
    Valderrama R; Eggers AE; Moomjy M; Kao PN; Michl J
    Clin Exp Immunol; 1988 Jul; 73(1):123-7. PubMed ID: 3168327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of human antibody and murine monoclonal antibody with muscle acetylcholine receptor.
    Dwyer DS; Kearney JF; Bradley RJ; Kemp GE; Oh SJ
    Ann N Y Acad Sci; 1981; 377():143-57. PubMed ID: 6951469
    [No Abstract]   [Full Text] [Related]  

  • 32. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological similarities between an experimental autoimmune myasthenia gravis model and human myasthenia gravis.
    Souan ML; Geffard M
    Neurosci Lett; 1986 Aug; 68(3):282-7. PubMed ID: 2427976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The auto-anti-idiotypic route to antireceptor antibodies.
    Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Wan KK; Sarangarajan R; Penn AS
    Ann N Y Acad Sci; 1986; 475():219-26. PubMed ID: 3491562
    [No Abstract]   [Full Text] [Related]  

  • 35. Idiotype restriction in myasthenia gravis antibodies.
    Vincent A
    Nature; 1981 Mar; 290(5804):293-4. PubMed ID: 7207623
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis.
    Lennon VA; Griesmann GE
    Neurology; 1989 Aug; 39(8):1069-76. PubMed ID: 2474772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor.
    Tzartos S; Hochschwender S; Vasquez P; Lindstrom J
    J Neuroimmunol; 1987 Jun; 15(2):185-94. PubMed ID: 3495549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular production of antibodies related to the acetylcholine receptor in myasthenia gravis: correlation with clinical stage.
    Lefvert AK; Holm G; Sundén H; Pirskanen R
    Scand J Immunol; 1987 Mar; 25(3):265-73. PubMed ID: 2436288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auto-anti-idiotypic immunity and acetylcholine receptors.
    Lefvert AK
    Concepts Immunopathol; 1986; 3():285-310. PubMed ID: 3297327
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity.
    Lennon VA; Lambert EH
    Ann N Y Acad Sci; 1981; 377():77-96. PubMed ID: 6176167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.